News
Kate Therapeutics and Capsida Biotherapeutics collaborate on gene therapies
Kate Therapeutics (KateTx) and Capsida Biotherapeutics have announced a strategic collaboration to manufacture KateTx’s next-generation gene therapies.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Kate Therapeutics (KateTx) and Capsida Biotherapeutics have announced a strategic collaboration to manufacture KateTx’s next-generation gene therapies.